Zydus Lifesciences has informed that it enclosed a copy of press release dated January 16, 2023 titled ‘Zydus receives tentative approval from the USFDA for Levomilnacipran Extended-Release Capsules’.
The above information is a part of company’s filings submitted to BSE.